AU2003213203A1 - Rna interference mediated inhibition of myc and myb genes or genes of their respective pathways - Google Patents
Rna interference mediated inhibition of myc and myb genes or genes of their respective pathwaysInfo
- Publication number
- AU2003213203A1 AU2003213203A1 AU2003213203A AU2003213203A AU2003213203A1 AU 2003213203 A1 AU2003213203 A1 AU 2003213203A1 AU 2003213203 A AU2003213203 A AU 2003213203A AU 2003213203 A AU2003213203 A AU 2003213203A AU 2003213203 A1 AU2003213203 A1 AU 2003213203A1
- Authority
- AU
- Australia
- Prior art keywords
- genes
- myc
- rna interference
- mediated inhibition
- myb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/332—Abasic residue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35858002P | 2002-02-20 | 2002-02-20 | |
US60/358,580 | 2002-02-20 | ||
US36312402P | 2002-03-11 | 2002-03-11 | |
US60/363,124 | 2002-03-11 | ||
US38678202P | 2002-06-06 | 2002-06-06 | |
US60/386,782 | 2002-06-06 | ||
US40678402P | 2002-08-29 | 2002-08-29 | |
US60/406,784 | 2002-08-29 | ||
US40837802P | 2002-09-05 | 2002-09-05 | |
US60/408,378 | 2002-09-05 | ||
US40929302P | 2002-09-09 | 2002-09-09 | |
US60/409,293 | 2002-09-09 | ||
US41865502P | 2002-10-15 | 2002-10-15 | |
US60/418,655 | 2002-10-15 | ||
US44012903P | 2003-01-15 | 2003-01-15 | |
US60/440,129 | 2003-01-15 | ||
PCT/US2003/005326 WO2003070917A2 (en) | 2002-02-20 | 2003-02-20 | Rna interference mediated inhibition of myc and myb genes or genes of their respective pathways |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003213203A1 true AU2003213203A1 (en) | 2003-09-09 |
AU2003213203A8 AU2003213203A8 (en) | 2003-09-09 |
Family
ID=27761723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003213203A Abandoned AU2003213203A1 (en) | 2002-02-20 | 2003-02-20 | Rna interference mediated inhibition of myc and myb genes or genes of their respective pathways |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1448590A4 (en) |
AU (1) | AU2003213203A1 (en) |
WO (1) | WO2003070917A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9181551B2 (en) | 2002-02-20 | 2015-11-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
US9657294B2 (en) | 2002-02-20 | 2017-05-23 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
WO2005047321A2 (en) * | 2003-11-14 | 2005-05-26 | Creighton University | Polynucleotides for inhibition of polypeptide expression and methods of use |
EP2899278A1 (en) | 2004-03-12 | 2015-07-29 | Alnylam Pharmaceuticals Inc. | iRNA agents targeting VEGF |
EP2287303B1 (en) | 2004-11-12 | 2014-07-02 | Asuragen, Inc. | Methods and compositions involving miRNA and miRNA inhibitor molecules |
WO2008055924A1 (en) * | 2006-11-07 | 2008-05-15 | Vib Vzw | Diagnosis and treatment of t-cell acute lymphoblastic leukemia |
US20100055782A1 (en) * | 2007-03-02 | 2010-03-04 | Mdrna, Inc. | Nucleic acid compounds for inhibiting myc gene expression and uses thereof |
TW200908998A (en) * | 2007-06-27 | 2009-03-01 | Oncotherapy Science Inc | Compositions and methods of treating cancer |
WO2009152387A2 (en) * | 2008-06-11 | 2009-12-17 | Intradigm Corporation | Compositions comprising cmyc sirna and methods of use thereof |
US9376679B2 (en) * | 2010-05-26 | 2016-06-28 | Micromedmark Biotech Co. Ltd. | Microvesicles carrying small interfering RNAs, preparation methods and uses thereof |
WO2012027206A1 (en) | 2010-08-24 | 2012-03-01 | Merck Sharp & Dohme Corp. | SINGLE-STRANDED RNAi AGENTS CONTAINING AN INTERNAL, NON-NUCLEIC ACID SPACER |
EP3327125B1 (en) | 2010-10-29 | 2020-08-05 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina) |
ITMI20120275A1 (en) * | 2012-02-24 | 2013-08-25 | Biogenera Societa A Responsabilita Limitata | OLIGONUCLEOTIDS FOR THE MODULATION OF GENE EXPRESSION AND THEIR USES |
EP2895609A4 (en) * | 2012-09-14 | 2016-10-05 | Dicerna Pharmaceuticals Inc | Methods and compostions for the specific inhibition of myc by double-stranded rna |
US9228189B2 (en) | 2012-10-26 | 2016-01-05 | Geron Corporation | C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders |
CN108884462B (en) | 2016-01-26 | 2022-11-25 | 日产化学株式会社 | Single-stranded oligonucleotides |
AU2018215440A1 (en) | 2017-02-06 | 2019-08-29 | Nissan Chemical Corporation | Single-stranded oligonucleotide |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0649467B1 (en) * | 1992-07-02 | 1998-09-16 | HYBRIDON, Inc. | Self-stabilized oligonucleotides as therapeutic agents |
US6323184B1 (en) * | 1993-10-15 | 2001-11-27 | Thomas Jefferson University | Arteriovenous and venous graft treatments: methods and compositions |
US6133242A (en) * | 1993-10-15 | 2000-10-17 | Thomas Jefferson Univerisity | Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
US20030166282A1 (en) * | 2002-02-01 | 2003-09-04 | David Brown | High potency siRNAS for reducing the expression of target genes |
-
2003
- 2003-02-20 EP EP03709249A patent/EP1448590A4/en not_active Withdrawn
- 2003-02-20 WO PCT/US2003/005326 patent/WO2003070917A2/en not_active Application Discontinuation
- 2003-02-20 AU AU2003213203A patent/AU2003213203A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1448590A2 (en) | 2004-08-25 |
EP1448590A4 (en) | 2004-12-15 |
WO2003070917A2 (en) | 2003-08-28 |
WO2003070917A3 (en) | 2004-02-05 |
AU2003213203A8 (en) | 2003-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003213203A1 (en) | Rna interference mediated inhibition of myc and myb genes or genes of their respective pathways | |
AU2002329667A1 (en) | Specific inhibition of gene expression by small double stranded rnas | |
AU2003298095A1 (en) | Identification of e2f target genes and uses thereof | |
HUP0103571A3 (en) | Characterisation of gene function using double stranded rna inhibition | |
WO2004044123A9 (en) | Bioinformatically detectable group of novel regulatory genes and uses thereof | |
GB2442373B (en) | Sequence -specific inhibition of small rna function | |
IL174767A0 (en) | Inhibition of fgrf3 and treatment of multiple myeloma | |
EP1539778A4 (en) | Deprotection and purification of oligonucleotides and their derivatives | |
AU2003213092A1 (en) | Syntheses of quinazolinones | |
AU2002311974A1 (en) | Transcriptional regulation of target genes | |
AU2003297474A1 (en) | Methods of inhibiting gene expression by rna interference | |
AU2003277303A1 (en) | Formation of corrosion-resistant coating | |
AU2003287254A1 (en) | Inhibition of gene expression using rna interfering agents | |
AU2002235520A1 (en) | Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer | |
AU2003222197A1 (en) | Inhibition of rna function | |
AU2003226380A1 (en) | Method of forming inorganic pigments | |
AU2003265884A8 (en) | Target and method for inhibition of bacterial rna polymerase | |
AU2003213042A1 (en) | Projectile jacket and method of making | |
AU2003260778A1 (en) | Treatment of pipes | |
AU2003234190A1 (en) | Inhibition of immune complex formation | |
AU2002233314A1 (en) | Regulation of human histone acetyltransferase | |
AU2003304240A1 (en) | INHIBITION OF EGR-1 EXPRESSION BY RPAR-Gamma AGONISTA AND RELATED COMPOSITIONS AND METHODS | |
AU2003257470A1 (en) | Detection of microorganisms | |
AU2003256931A1 (en) | USES OF CIRCADIAN GENE mPER2 | |
AU2002219992A1 (en) | Targeted regulation of gene expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |